Skip to main content
. 2012 May 6;10:46. doi: 10.1186/1477-7525-10-46

Table 1.

Demographic and clinical baseline data for the study patients (n = 252), according to physical and mental component summary-36 score quartiles

 
All patients
Physical component summary-36 score quartiles
Mental component summary-36 score quartiles
    Q 1 Range: 9.6-30.0 Q 2 Range: 30.1-35.6 Q 3 Range: 35.7-44.4 Q 4 Range: 44.5–58.2 P -value Q 1 Range: 16.9-39.2 Q 2 Range: 39.3-49.0 Q 3 Range: 49.1-55.6 Q 4 Range: 55.7-70.7 P - value
N
252
63
63
63
63
 
63
63
63
63
 
Age, yrs, (252)
60.2±15.5
60.8±12.4
64.8±14.9
58.1±17.3
57.2±16.0
0.027p
56.5±15.7
63.7±15.3
60.0±17.0
60.6±13.0
0.071p
Male gender,%, (n=252)
65.9 (166)
58.7 (37)
68.3 (43)
69.8 (44)
66.7 (42)
0.5632
61.9 (39)
68.3 (43)
77.8 (49)
55.6 (35)
0.0562
Current smoker, %, (n=252)
25.8 (65)
33.3 (21)
23.8 (15)
22.2 (14)
23.8 (15)
0.466 2
39.7 (25)
22.2 (14)
19.0 (12)
22.2 (14)
0.0342
Work status, %, (n)
Able to work, (n=235)
12.3 (29)
8.5 (5)
5.2 (3)
12.1 (7)
23.3 ( 14)
0.016 2
6.7 (4)
15.3 (9)
12.7 (7)
14.8 (9)
0.4602
Disable to work, (n=235)
51.5 (121)
64.4 (38)
43.1 (25)
50.0 (29)
48.3 (29)
0.118 2
65.0 (39)
35.6 (21)
47.3 (26)
57.4 (35)
0.0092
Retired, (n=235)
36.2 (85)
27.1 (16)
51.7 (30)
37.9 (22)
28.3 (17)
0.02 2
28.3 (17)
49.2 (29)
40.0 (22)
27.9 (17)
0.0452
Cause of renal failure, %, (n)
Glomerulonephritis, (n=249)
20.5 (51)
14.3 (9)
20.6 (13)
19.4 (12)
27.9 (17)
0.311 2
20.6 (13)
12.7 (8)
26.7 (16)
22.2 (14)
0.2762
Diabetic nephropathy, (n=249)
14.1 (35)
22.2 (14)
6.3 (4)
16.1 (10)
11.5 (7)
0.068 2
15.9 (10)
14.3 (9)
16.7 (10)
9.5 (6)
0.6632
Hypertensive kidney disease, (n=249)
24.9 (62)
25.4 (16)
25.4 (16)
27.4 (17)
21.3 (13)
0.886 2
25.4 (16)
25.4 (16)
23.3 (14)
25.4 (16)
0.9912
Other, (n=249)
40.6 (101)
38.1 (24)
47.6 (30)
37.1 (23)
39.3 (24)
0.613 2
38.1 (24)
47.6 (30)
33.3 (20)
42.9 (27)
0.4082
Clinical variables
Dialysis vintage, mo, (n=251)
9.0 (5.0, 23.0)
18.0 (6.0, 34.0)
9.0 (4.0, 20.0)
9.0 (5.0, 20.0)
7.0 (3.4, 16.8)
0.004np
10.0 (4.0, 23.0)
11.0 (5.0, 32.0)
10.0 (5.0, 17.3)
7.0 (4.0, 24.0)
0.352np
Previous graft failure, (251)
18.7 (47)
24.2 (15)
11.1 (7)
19.0 (12)
20.6 (13)
0.287 2
22.2 (14)
17.5 (11)
21.0 (13)
14.3 (9)
0.6612
Accepted for renal transplantation, (n=252)
38.1 (96)
28.6 (18)
27.0 (17)
49.2 (31)
47.6 (30)
0.012
36.5 (23)
33.3 (21)
42.9 (27)
39.7 (25)
0.7182
Peritoneal dialysis, (n=252)
20.2 (51)
23.8 (15)
14.3 (9)
27.0 (17)
15.9 (10)
0.221 2
14.3 (9)
19.0 (12)
31.7 (20)
15.9 (10)
0.0622
Body mass index, kg/m2, (n=235)
24.9±4.9
23.6±5.0
25.5±4.8
24.9±4.6
25.5±5.0
0.135p
23.7±4.5
25.2±4.4
25.0±4.6
25.9±5.8
0.124p
Serum albumin, g/l, (n=246)
38.0±4.8
36.6±5.9
37.7±4.4
38.4±4.3
39.1±4.0
0.022p
38.7±3.9
37.8±4.4
38.1±5.5
37.4±5.2
0.503p
Hemoglobin, g/dl, (n=246)
12.1±1.5
12.0±1.4
12.1±1.5
12.2±1.5
12.2±1.4
0.87p
11.8±1.6
12.1±1.3
12.4±1.5
12.2±1.3
0.139p
Total cholesterol, mmol/L, (n=230)
4.2±1.1
4.0±1.2
4.1±1.1
4.5±1.1
4.2±1.1
0.103p
4.3±1.2
4.0±1.0
4.2±1.2
4.3±1.1
0.279p
Comorbidity
Diabetes, %, (n=250)
26.4 (66)
31.7 (20)
28.6 (18)
24.2 (15)
21.0 (13)
0.537 2
30.2 (19)
33.3 (21)
27.9 (17)
14.3 (9)
0.0772
CCI without age, (n=248) 4 (2, 5) 5 (4, 6) 4 (2, 4) 3 (2, 5) 3 (2, 4) <0.001np 4 (3, 5) 4 (3, 5) 4 (2, 5) 3 (2, 5) 0.436np

CCI Charlson modified comorbidity index. Continuous variables are given as mean ± SD, when normally distributed, or as median (IQR), when skewed. P-values between the four groups are calculated based on parametric (ANOVA)p , nonparametric (Kruskall Wallis)np, or Chi-squared2 statistics. Note: Numbers of complete data are given in parentheses for each variable.